Cargando…
Evaluation of a Novel In-house HIV-1 Genotype Drug Resistance Assay using Clinical Samples in China
BACKGROUND: HIV drug resistance poses a major challenge for anti-retroviral treatment (ART) and the prevention and control of HIV epidemic. OBJECTIVE: The study aims to establish a novel in-house assay with high efficiency, named AP in- house method, that would be suitable for HIV-1 drug resistance...
Autores principales: | Gao, Peijie, Yu, Fengting, Yang, Xiaozhen, Li, Dan, Shi, Yalun, Wang, Yan, Zhang, Fujie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9127726/ https://www.ncbi.nlm.nih.gov/pubmed/34515004 http://dx.doi.org/10.2174/1570162X19666210910144433 |
Ejemplares similares
-
HIV-1C in-House RNA-Based Genotyping Assay for Detection of Drug Resistance Mutations in Samples with Low-Level Viral Loads
por: Bareng, Ontlametse T, et al.
Publicado: (2022) -
HIV-1 Genotypic Resistance Testing Using Sanger and Next-Generation Sequencing in Adults with Low-Level Viremia in China
por: Li, Qun, et al.
Publicado: (2022) -
A Concentration Method for HIV Drug Resistance Testing in Low-Level Viremia Samples
por: Li, Qun, et al.
Publicado: (2022) -
Drug Resistance to HIV-1 Integrase Inhibitors Among Treatment-Naive Patients in Beijing, China
por: Yu, Fengting, et al.
Publicado: (2022) -
Evaluation of a Cost Effective In-House Method for HIV-1 Drug Resistance Genotyping Using Plasma Samples
por: Chaturbhuj, Devidas N., et al.
Publicado: (2014)